Our data indicate that ICAM-1 activation following TBI induced a significant impairment in sensorimotor function as monitored by rotarod and grid walk test and severely exacerbate depression and anxiety-like psychological stress as monitored by the sucrose preference test and the light-dark test. Here, ICAM1 is linked to depressive symptom measurement.